Abbott Laboratories (ABT)

R&D to Revenue

7.00%

Quarterly · Period ending:

ABT logo

ABT R&D to Revenue

Latest reported7.00%
ABT Quarterly R&D/Revenue (0.00% → 7.00%)
High-resolution chart · PNG

ABT r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Abbott Laboratories R&D to Revenue — Quarterly
Period endingR&D to Revenue
7.0039%
6.7718%
6.4142%
6.9047%
6.5697%
6.787%
6.6339%
6.7043%
6.7168%
6.8547%
6.7376%
6.5168%
7.1157%
6.7098%
6.8477%
7.4928%
6.0762%
5.8596%
6.6097%
6.1493%
6.3973%
6.2548%
6.5228%
6.5515%
7.6965%
7.4553%
6.916%
7.3551%
7.2315%
8.8918%
7.2247%
7.4843%
7.3774%
7.862%
8.1434%
7.2192%
7.8349%
8.5399%
6.3379%
6.3372%
6.5254%
7.7584%
7.1126%
7.3398%
6.6731%
6.3917%
6.7401%
6.0149%
6.0349%
7.3799%
6.8258%
6.6493%
6.6654%
6.4336%
10.5328%
11.9104%
10.309%
10.6376%
11.0972%
10.2883%
10.7945%
10.2865%
12.9981%
12.438%
9.7213%
9.483%
8.4987%
8.7102%
8.9393%
9.686%
9.2026%
9.0743%
8.9809%
9.1634%
9.1728%
10.0478%
9.1588%
10.9328%
9.5878%
11.0809%
19.075%
9.3594%
8.1092%
8.3371%
8.0607%
8.1122%
8.2054%
8.3666%
9.2814%
8.2251%
8.782%
9.0592%
8.5263%
8.8643%
8.9372%
9.0556%
8.7949%
8.5141%
10.3793%
9.5802%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.